Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
<p>Abstract</p> <p>Background</p> <p>The development of an effective vaccine against visceral leishmaniasis (VL) caused by <it>Leishmania donovani </it>is an essential aim for controlling the disease. Use of the right adjuvant is of fundamental importance in vaccine formulations for generation of ef...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2010-06-01
|
| シリーズ: | BMC Microbiology |
| オンライン･アクセス: | http://www.biomedcentral.com/1471-2180/10/181 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|